VJHemOnc is committed to improving our service to you

EBMT 2020 | CMWP & EBMT report: allogeneic HCT outcomes in myeloma patients on renal replacement

VJHemOnc is committed to improving our service to you

Meral Beksac

Meral Beksac, MD, Ankara University School of Medicine, Ankara, Turkey, discusses a Chronic Malignancies Working Party (CMWP) and European Society for Blood and Marrow Transplantation (EBMT) report that investigated allogeneic hematopoietic cell transplantation (HCT) outcomes in myeloma patients on renal replacement. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter